NASDAQ : TLX

Telix Pharmaceuticals Limited

$11.29 USD

$0.27 (2.45%)

Volume
56.58K
Average Volume
185.39K
Market Capitalization
$3.82B
P/E Ratio
-486.29
Dividend Yield
0.00%
Price Target
$20.00
Year High
$16.94
Year Low
$6.28
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.43

TLX Estimated and Actual Revenue by Quarter

TLX Estimated and Actual EPS by Quarter

TLX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2030-12-31 1 -2.93B -2.93B -2.93B -3.11B -3.11B -3.11B
2030-06-30 1 -285.07M -285.07M -285.07M -302.35M -302.35M -302.35M
2029-12-31 1 -249.38M -249.38M -249.38M -264.49M -264.49M -264.49M
2029-06-30 1 -193.36M -193.36M -193.36M -205.08M -205.08M -205.08M
2028-12-31 1 -180.01M -180.01M -180.01M -190.92M -190.92M -190.92M
2028-06-30 1 -52.3M -52.3M -52.3M -55.47M -55.47M -55.47M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2030-12-31 1 143.72M 143.72M 143.72M 16.49B 16.49B 16.49B
2030-06-30 1 115.37M 115.37M 115.37M 1.6B 1.6B 1.6B
2029-12-31 1 80.02M 80.02M 80.02M 1.4B 1.4B 1.4B
2029-06-30 1 7.66M 7.66M 7.66M 1.09B 1.09B 1.09B
2028-12-31 1 8.74M 8.74M 8.74M 1.01B 1.01B 1.01B
2028-06-30 1 44.76M 44.76M 44.76M 294.38M 294.38M 294.38M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2030-12-31 1 10.91B 10.91B 10.91B 1 0.42423 0.42423 0.42423
2030-06-30 1 1.06B 1.06B 1.06B 1 0.34055 0.34055 0.34055
2029-12-31 1 928.76M 928.76M 928.76M 1 0.23619 0.23619 0.23619
2029-06-30 1 720.12M 720.12M 720.12M 1 0.02262511 0.02262511 0.02262511
2028-12-31 1 670.41M 670.41M 670.41M 1 0.02580782 0.02580782 0.02580782
2028-06-30 1 194.77M 194.77M 194.77M 1 0.13212 0.13212 0.13212